Header Logo

Connection

David Bennett to Disease Progression

Back to Details
This is a "connection" page, showing publications David Bennett has written about Disease Progression.
David Bennett
Connection Strength
5.669
Disease Progression
  1. Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline. JAMA Neurol. 2020 10 01; 77(10):1217-1224.
    View in: PubMed
    Score: 0.583
  2. Parsing the heterogeneity of mild cognitive impairment: Lumpers and splitters. Neurology. 2015 Nov 10; 85(19):1646-7.
    View in: PubMed
    Score: 0.413
  3. Harm avoidance is associated with progression of parkinsonism in community-dwelling older adults: a prospective cohort study. BMC Geriatr. 2014 Apr 23; 14:54.
    View in: PubMed
    Score: 0.373
  4. Visuoperceptual repetition priming and progression of parkinsonian signs in aging. Neurobiol Aging. 2009 Mar; 30(3):441-9.
    View in: PubMed
    Score: 0.235
  5. Relationship of Purpose in Life to Dementia in Older Black and White Brazilians. J Int Neuropsychol Soc. 2022 11; 28(10):997-1002.
    View in: PubMed
    Score: 0.157
  6. Person-Specific Contributions of Brain Pathologies to Progressive Parkinsonism in Older Adults. J Gerontol A Biol Sci Med Sci. 2021 03 31; 76(4):615-621.
    View in: PubMed
    Score: 0.151
  7. Variability and Coupling of Olfactory Identification and Episodic Memory in Older Adults. J Gerontol B Psychol Sci Soc Sci. 2020 02 14; 75(3):577-584.
    View in: PubMed
    Score: 0.140
  8. Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology. 2019 04 16; 92(16):e1821-e1830.
    View in: PubMed
    Score: 0.131
  9. Incident parkinsonism in older adults without Parkinson disease. Neurology. 2016 Sep 06; 87(10):1036-44.
    View in: PubMed
    Score: 0.109
  10. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
    View in: PubMed
    Score: 0.107
  11. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.100
  12. Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology. 2014; 43(2):131-9.
    View in: PubMed
    Score: 0.097
  13. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci. 2014 Dec; 69(12):1536-44.
    View in: PubMed
    Score: 0.095
  14. Association of brain pathology with the progression of frailty in older adults. Neurology. 2013 May 28; 80(22):2055-61.
    View in: PubMed
    Score: 0.087
  15. The natural history of cognitive decline in Alzheimer's disease. Psychol Aging. 2012 Dec; 27(4):1008-17.
    View in: PubMed
    Score: 0.083
  16. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2012; 39(2):73-83.
    View in: PubMed
    Score: 0.083
  17. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.075
  18. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.073
  19. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010; 34(1):43-9.
    View in: PubMed
    Score: 0.069
  20. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009 Sep 22; 73(12):920-7.
    View in: PubMed
    Score: 0.067
  21. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.066
  22. NSAID exposure and risk of Alzheimer disease: is timing everything? Neurology. 2009 Jun 02; 72(22):1884-5.
    View in: PubMed
    Score: 0.066
  23. Repetition priming and change in functional ability in older persons without dementia. Neuropsychology. 2009 Jan; 23(1):98-104.
    View in: PubMed
    Score: 0.065
  24. Odor identification and progression of parkinsonian signs in older persons. Exp Aging Res. 2008 Jul-Sep; 34(3):173-87.
    View in: PubMed
    Score: 0.062
  25. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry. 2008 Apr; 65(4):439-45.
    View in: PubMed
    Score: 0.061
  26. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct; 64(10):1204-12.
    View in: PubMed
    Score: 0.059
  27. Chronic distress and incidence of mild cognitive impairment. Neurology. 2007 Jun 12; 68(24):2085-92.
    View in: PubMed
    Score: 0.058
  28. Terminal cognitive decline: accelerated loss of cognition in the last years of life. Psychosom Med. 2007 Feb-Mar; 69(2):131-7.
    View in: PubMed
    Score: 0.057
  29. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006 Aug 08; 67(3):441-5.
    View in: PubMed
    Score: 0.055
  30. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005 Sep 27; 65(6):892-7.
    View in: PubMed
    Score: 0.052
  31. Education modifies the association of amyloid but not tangles with cognitive function. Neurology. 2005 Sep 27; 65(6):953-5.
    View in: PubMed
    Score: 0.052
  32. Mild cognitive impairment: is it Alzheimer's disease or not? J Alzheimers Dis. 2005 Jun; 7(3):241-5; discussion 255-62.
    View in: PubMed
    Score: 0.050
  33. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005 Mar 08; 64(5):834-41.
    View in: PubMed
    Score: 0.050
  34. Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex. J Neural Transm (Vienna). 2005 Aug; 112(8):1049-56.
    View in: PubMed
    Score: 0.049
  35. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology. 2004 Sep 28; 63(6):996-1001.
    View in: PubMed
    Score: 0.048
  36. Mild cognitive impairment. Clin Geriatr Med. 2004 Feb; 20(1):15-25.
    View in: PubMed
    Score: 0.046
  37. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 2003 Apr; 60(4):539-44.
    View in: PubMed
    Score: 0.043
  38. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003 Jan 28; 60(2):246-52.
    View in: PubMed
    Score: 0.043
  39. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry. 2002 Dec; 73(6):672-7.
    View in: PubMed
    Score: 0.042
  40. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
    View in: PubMed
    Score: 0.042
  41. Progression of gait disorder and rigidity and risk of death in older persons. Neurology. 2002 Jun 25; 58(12):1815-9.
    View in: PubMed
    Score: 0.041
  42. Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology. 2022 05 17; 98(20):e2036-e2045.
    View in: PubMed
    Score: 0.040
  43. Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community-based cohort study. Alzheimers Dement. 2022 12; 18(12):2551-2559.
    View in: PubMed
    Score: 0.040
  44. Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging. JAMA Neurol. 2021 12 01; 78(12):1494-1502.
    View in: PubMed
    Score: 0.040
  45. Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults. Lancet Healthy Longev. 2020 12; 1(3):e96-e105.
    View in: PubMed
    Score: 0.037
  46. Part II. Clinical diagnosis and course of Alzheimer's disease. Dis Mon. 2000 Oct; 46(10):666-86.
    View in: PubMed
    Score: 0.036
  47. Association of Cardiovascular Risk Burden With Risk and Progression of Disability: Mediating Role of Cardiovascular Disease and Cognitive Decline. J Am Heart Assoc. 2020 09 15; 9(18):e017346.
    View in: PubMed
    Score: 0.036
  48. Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep. 2020 08 20; 10(1):14059.
    View in: PubMed
    Score: 0.036
  49. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020 10 06; 95(14):e1951-e1962.
    View in: PubMed
    Score: 0.036
  50. Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. Brain. 2020 07 01; 143(7):2272-2280.
    View in: PubMed
    Score: 0.036
  51. Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways. Alzheimers Dement. 2020 08; 16(8):1134-1145.
    View in: PubMed
    Score: 0.036
  52. Association of lifespan cognitive reserve indicator with the risk of mild cognitive impairment and its progression to dementia. Alzheimers Dement. 2020 06; 16(6):873-882.
    View in: PubMed
    Score: 0.035
  53. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
    View in: PubMed
    Score: 0.035
  54. Total Daily Physical Activity and the Risk of Parkinsonism in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2020 03 09; 75(4):702-711.
    View in: PubMed
    Score: 0.035
  55. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.035
  56. Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study. J Alzheimers Dis. 2020; 78(3):1245-1257.
    View in: PubMed
    Score: 0.035
  57. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
    View in: PubMed
    Score: 0.034
  58. Common age-related neuropathologies and yearly variability in cognition. Ann Clin Transl Neurol. 2019 11; 6(11):2140-2149.
    View in: PubMed
    Score: 0.034
  59. Interaction between the progression of Alzheimer's disease and fractal degradation. Neurobiol Aging. 2019 11; 83:21-30.
    View in: PubMed
    Score: 0.034
  60. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019 06; 570(7761):332-337.
    View in: PubMed
    Score: 0.033
  61. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.032
  62. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.031
  63. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. J Alzheimers Dis. 2018; 62(2):855-865.
    View in: PubMed
    Score: 0.030
  64. MIND Diet Associated with Reduced Incidence and Delayed Progression of ParkinsonismA in Old Age. J Nutr Health Aging. 2018; 22(10):1211-1215.
    View in: PubMed
    Score: 0.030
  65. Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study. Neurology. 2018 01 16; 90(3):e214-e222.
    View in: PubMed
    Score: 0.030
  66. Are latent variable models preferable to composite score approaches when assessing risk factors of change? Evaluation of type-I error and statistical power in longitudinal cognitive studies. Stat Methods Med Res. 2019 07; 28(7):1942-1957.
    View in: PubMed
    Score: 0.030
  67. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.028
  68. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016 09 01; 73(9):1062-9.
    View in: PubMed
    Score: 0.027
  69. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015 Sep; 11(9):1015-22.
    View in: PubMed
    Score: 0.025
  70. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015 Sep; 11(9):1007-14.
    View in: PubMed
    Score: 0.025
  71. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology. 2014 Oct 14; 83(16):1410-6.
    View in: PubMed
    Score: 0.024
  72. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement. 2015 Jan; 11(1):70-98.
    View in: PubMed
    Score: 0.024
  73. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6):666-74.
    View in: PubMed
    Score: 0.023
  74. Association between performance on Timed Up and Go subtasks and mild cognitive impairment: further insights into the links between cognitive and motor function. J Am Geriatr Soc. 2014 Apr; 62(4):673-8.
    View in: PubMed
    Score: 0.023
  75. AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol. 2013; 35(1):24-34.
    View in: PubMed
    Score: 0.021
  76. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol. 2010 Apr; 67(4):475-82.
    View in: PubMed
    Score: 0.018
  77. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.017
  78. Early risk assessment for Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):182-96.
    View in: PubMed
    Score: 0.016
  79. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging. 2010 Jul; 31(7):1089-98.
    View in: PubMed
    Score: 0.016
  80. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci. 2007 Oct 03; 27(40):10810-7.
    View in: PubMed
    Score: 0.015
  81. Mild cognitive impairment. Lancet. 2006 Apr 15; 367(9518):1262-70.
    View in: PubMed
    Score: 0.013
  82. Change in cognitive function in Alzheimer's disease in African-American and white persons. Neuroepidemiology. 2006; 26(1):16-22.
    View in: PubMed
    Score: 0.013
  83. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc. 2005 Jul; 11(4):446-53.
    View in: PubMed
    Score: 0.013
  84. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology. 2005 May 10; 64(9):1520-4.
    View in: PubMed
    Score: 0.013
  85. Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology. 2005 Jan; 30(1):11-7.
    View in: PubMed
    Score: 0.012
  86. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004 Oct; 25(9):1197-203.
    View in: PubMed
    Score: 0.012
  87. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J Neurosci. 2004 Sep 08; 24(36):7895-902.
    View in: PubMed
    Score: 0.012
  88. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004 Jun 08; 62(11):2021-4.
    View in: PubMed
    Score: 0.012
  89. Cognitive activity and cognitive decline in a biracial community population. Neurology. 2003 Sep 23; 61(6):812-6.
    View in: PubMed
    Score: 0.011
  90. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 2002 Oct; 177(2):475-93.
    View in: PubMed
    Score: 0.010
  91. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging. 2001 Sep-Oct; 22(5):747-54.
    View in: PubMed
    Score: 0.010
  92. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2001 Aug 27; 437(3):296-307.
    View in: PubMed
    Score: 0.010
  93. Decline of language among women and men with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2000 Nov; 55(6):P354-60.
    View in: PubMed
    Score: 0.009
  94. Progression of parkinsonism and loss of cognitive function in Alzheimer disease. Arch Neurol. 2000 Jun; 57(6):855-60.
    View in: PubMed
    Score: 0.009
  95. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999 Sep 06; 411(4):693-704.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.